SOURCE: Grupo International Inc.

September 16, 2010 09:00 ET

Grupo International Expands Its Most Recent Facility

SAN DIEGO, CA--(Marketwire - September 16, 2010) -  Grupo International Inc. (formally "HIV-VAC, Inc.") current stock symbol (PINKSHEETS: HIVV) -- President Ramon Richard announced that the Company will expand its newest "RiMart" Store. "RiMart" has recently opened an Ensenada store location, and will expand it to serve as a mini warehouse. This location will carry many of its bulk items which will allow it to increase its ability in supplying specialty products for large construction companies as well products used in the farm industry. This Ensenada store location is 10 times the size of our average stores and will offer everything from cement blocks to wooden pallets. "RiMart" has been able to develop a favorable trade business with major builders in Mexico. "RiMart" specializes in supplying building materials such as cement, steel, blocks, and hand tools for many of the major construction projects.

Grupo International Inc., formally HIV-VAC, Inc., agree to acquire 80% of "Richard Y Lange" S.A.De.C.V. as part of the Company's restructure and recapitalization. The Company is also in the process of changing its symbol so that it will better reflect its international standing and direction. Grupo International operates two divisions; "HIV-VAC" which continues the development of vaccines and "Richard Y Lange." The "Richard y Lange" division operates under the names of "RiMart," which presently operates 14 tool retail stores throughout Baja California; "GR Construction" specializing in large industrial projects; "Block GRYLSA" which operates block manufacturing facilities; and "GRYLSA," a raw materials division that mines commercial grade sand located near the border of the State of California and Baja California.

For more information, please check the Company's information or web site below.

Safe Harbor: The information contained in this press release, including any "forward looking" statements within the meaning of section 27A of the securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 contained herein, should be reviewed in conjunction with the Company's Annual Report on Form 10-KSB and other publicly available information regarding the Company, copies of which are available from the Company upon request. Such publicly available information sets forth many risks and uncertainties related to the Company's business and such statements, including risks and uncertainties related to that are unpredictable and outside of the influence and/or control of the Company. In particular, these risks and uncertainties include, without limitation: that third parties may be successful in challenging the patent issued; that granted claims may be held invalid or interpreted differently by a court of law; that other patents will issue that will block the Company from commercializing the technology covered by the patents; and that the benefits that Company believes can be derived from the patented technology will not be realized due to difficulties encountered in the long and expensive process of the development of new technologies and the cost and uncertainty in obtaining regulatory approval for products based on these technologies. In addition, there are many other risks and uncertainties inherent in the development of the Company's products, including the risk of not obtaining regulatory approval for a variety of reasons and the risk of adverse side effects in humans. Other risks relating to Company are detailed from time to time in documents filed by Company with the SEC.

Contact Information

  • CONTACT:
    HIV-VAC, Inc.
    Kevin W. Murray
    CFO
    12 Harben Court
    Collingwood, Ontario, Canada L9Y 4L8
    Tel: (705) 444-6317

    Web Site: www.grupointl.com
    Investor Relations: ir@grupointl.com
    Contact Number: 702-952-3998